Skip to content

HR 10336 · 119th Congress

To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.

Introduced Sep 10, 2026Last action Sep 10, 2026Congress.gov →

Latest action

Referred to the House Committee on Energy and Commerce.

Sponsor

Diana HarshbargerRepublican · TN-1Profile →